£68.41

Elsevier The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America (Volume 31-4) (The Clinics: Internal Medicine, Volume 31-4)

Price data last checked 95 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£68 today · previous high £68 · all-time low £67

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 636 days • 636 data points (No recent data available)

Historical
Generating forecast...
£68.41 £67.06 £67.35 £67.65 £67.94 £68.24 £68.53 11 June 2024 16 November 2024 24 April 2025 30 September 2025 08 March 2026

Price Distribution

Price distribution over 636 days • 2 price levels

Days at Price
Current Price
19 days 617 days · current 0 154 309 463 617 £67 £68 Days at Price

Price Analysis

Most common price: £68 (617 days, 97.0%)

Price range: £67 - £68

Price levels: 2 different prices over 636 days

Description

This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!

Product Specifications

Format
Hardcover
Domain
Amazon UK
Release Date
29 September 2017
Listed Since
12 January 2017

Barcode

No barcode data available

Similar Products You Might Like

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
98% match

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Springer

£92.42 08 Jan 2026
CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)
98% match

CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)

£113.67 09 Jan 2026
Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America: Volume 35-4 (The Clinics: Internal Medicine, Volume 35-4)
97% match

Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America: Volume 35-4 (The Clinics: Internal Medicine, Volume 35-4)

Elsevier

£71.63 27 Feb 2026
Myeloproliferative Neoplasms, An Issue of Hematology/Oncology Clinics of North America: Volume 35-2 (The Clinics: Internal Medicine, Volume 35-2)
97% match

Myeloproliferative Neoplasms, An Issue of Hematology/Oncology Clinics of North America: Volume 35-2 (The Clinics: Internal Medicine, Volume 35-2)

Elsevier

£71.63 26 Feb 2026
Chemotherapy for Leukemia: Novel Drugs and Treatment
97% match

Chemotherapy for Leukemia: Novel Drugs and Treatment

Springer

£105.45 09 Mar 2026
Myelodysplastic Syndromes, An Issue of Hematology/Oncology Clinics of North America (Volume 34-2) (The Clinics: Internal Medicine, Volume 34-2)
97% match

Myelodysplastic Syndromes, An Issue of Hematology/Oncology Clinics of North America (Volume 34-2) (The Clinics: Internal Medicine, Volume 34-2)

Elsevier

£68.52 26 Feb 2026
Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)
97% match

Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)

Humana

£96.51 12 Apr 2026
Leukemias
97% match

Leukemias

Springer

£76.02 18 Apr 2026
Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)
97% match

Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)

Humana

£84.99 17 Mar 2026
Oxford Specialist Handbook: Myeloproliferative Neoplasms (Oxford Specialist Handbooks in Oncology)
96% match

Oxford Specialist Handbook: Myeloproliferative Neoplasms (Oxford Specialist Handbooks in Oncology)

Oxford University Press

£68.99 01 Mar 2026
Acute Myelogenous Leukemia (Contemporary Hematology)
96% match

Acute Myelogenous Leukemia (Contemporary Hematology)

Humana

£164.16 09 Jan 2026
Acute Myeloid Leukemia (Hematologic Malignancies)
96% match

Acute Myeloid Leukemia (Hematologic Malignancies)

£92.25 08 Jan 2026
Managing Infections in Patients With Hematological Malignancies (Contemporary Hematology)
96% match

Managing Infections in Patients With Hematological Malignancies (Contemporary Hematology)

Humana

£79.93 25 Feb 2026
Springer Hematologic Cancers: Molecular Pathobiology to Therapy
96% match

Springer Hematologic Cancers: Molecular Pathobiology to Therapy

Springer

£113.48 20 Apr 2026
Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America (Volume 27-2) (The Clinics: Internal Medicine, Volume 27-2)
96% match

Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America (Volume 27-2) (The Clinics: Internal Medicine, Volume 27-2)

Elsevier

£53.98 20 Feb 2026
Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics
96% match

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

£116.62 13 Jan 2026
Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics
96% match

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

Springer

£122.70 07 Mar 2026
Blastic Plasmacytoid Dendritic Cell Neoplasm, An Issue of Hematology/Oncology Clinics of North America: Volume 34-3 (The Clinics: Internal Medicine, Volume 34-3)
96% match

Blastic Plasmacytoid Dendritic Cell Neoplasm, An Issue of Hematology/Oncology Clinics of North America: Volume 34-3 (The Clinics: Internal Medicine, Volume 34-3)

Elsevier

£68.52 26 Feb 2026
Consulting Hematology and Oncology Handbook
96% match

Consulting Hematology and Oncology Handbook

Springer

£57.66 08 Mar 2026
Myeloproliferative Neoplasms: Biology and Therapy (Contemporary Hematology)
96% match

Myeloproliferative Neoplasms: Biology and Therapy (Contemporary Hematology)

Humana

£79.98 13 Jan 2026
Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)
96% match

Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)

CRC Press

£147.25 13 Apr 2026
Leukemia and Related Disorders: Integrated Treatment Approaches (Contemporary Hematology)
96% match

Leukemia and Related Disorders: Integrated Treatment Approaches (Contemporary Hematology)

Humana

£79.98 22 Jan 2026
Acute Leukemias (Hematologic Malignancies)
96% match

Acute Leukemias (Hematologic Malignancies)

Springer

£103.69 12 Jan 2026
Molecular Genetics and Therapy of Leukemia: 84 (Cancer Treatment and Research, 84)
96% match

Molecular Genetics and Therapy of Leukemia: 84 (Cancer Treatment and Research, 84)

Springer

£211.51 06 Jan 2026